These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 21094356

  • 1. Predictors of death and occurrence of appropriate implantable defibrillator therapies in patients with ischemic cardiomyopathy.
    Ng AC, Bertini M, Borleffs CJ, Delgado V, Boersma E, Piers SR, Thijssen J, Nucifora G, Shanks M, Ewe SH, Biffi M, van de Veire NR, Leung DY, Schalij MJ, Bax JJ.
    Am J Cardiol; 2010 Dec 01; 106(11):1566-73. PubMed ID: 21094356
    [Abstract] [Full Text] [Related]

  • 2. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J, Piekarz J, Rydlewska A, Majewski J, Senderek T, Ząbek A, Małecka B.
    Kardiol Pol; 2012 Dec 01; 70(12):1264-75. PubMed ID: 23264245
    [Abstract] [Full Text] [Related]

  • 3. Left ventricular ejection fraction and absence of ACE inhibitor/angiotensin II receptor blocker predicts appropriate defibrillator therapy in the primary prevention population.
    Obeyesekere MN, Chan W, Stub D, Prabhu S, Teo EP, Toogood G, Mariani J, Broughton A, Kistler PM.
    Pacing Clin Electrophysiol; 2010 Jun 01; 33(6):696-704. PubMed ID: 20059719
    [Abstract] [Full Text] [Related]

  • 4. Survival and appropriate device interventions in recipients of cardioverter defibrillators implanted for the primary versus secondary prevention of sudden cardiac death.
    Stockburger M, Krebs A, Nitardy A, Habedank D, Celebi O, Knaus T, Dietz R.
    Pacing Clin Electrophysiol; 2009 Mar 01; 32 Suppl 1():S16-20. PubMed ID: 19250084
    [Abstract] [Full Text] [Related]

  • 5. Long-term predictors of mortality in ICD patients with non-ischaemic cardiac disease: impact of renal function.
    Schefer T, Wolber T, Binggeli C, Holzmeister J, Brunckhorst C, Duru F.
    Europace; 2008 Sep 01; 10(9):1052-9. PubMed ID: 18687703
    [Abstract] [Full Text] [Related]

  • 6. Characteristics of ventricular tachyarrhythmias occurring in ischemic versus nonischemic patients implanted with a biventricular cardioverter-defibrillator for primary or secondary prevention of sudden death.
    Boriani G, Gasparini M, Lunati M, Santini M, Landolina M, Vincenti A, Curnis A, Bocchiardo M, Padeletti L, Biffi M, Allaria L, Denaro A, InSync ICD Italian Registry Investigators.
    Am Heart J; 2006 Sep 01; 152(3):527.e1-11. PubMed ID: 16923425
    [Abstract] [Full Text] [Related]

  • 7. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial.
    Saxon LA, Bristow MR, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, Feldman AM, Galle E, Ecklund F.
    Circulation; 2006 Dec 19; 114(25):2766-72. PubMed ID: 17159063
    [Abstract] [Full Text] [Related]

  • 8. Predictors of appropriate implantable cardioverter defibrillator (ICD) therapy in primary prevention patients with ischemic and nonischemic cardiomyopathy.
    Verma A, Sarak B, Kaplan AJ, Oosthuizen R, Beardsall M, Wulffhart Z, Higenbottam J, Khaykin Y.
    Pacing Clin Electrophysiol; 2010 Mar 19; 33(3):320-9. PubMed ID: 19796352
    [Abstract] [Full Text] [Related]

  • 9. Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy.
    Desai AD, Burke MC, Hong TE, Kim S, Salem Y, Yong PG, Knight BP.
    J Cardiovasc Electrophysiol; 2006 May 19; 17(5):486-90. PubMed ID: 16684019
    [Abstract] [Full Text] [Related]

  • 10. Usefulness of microvolt T-wave alternans on predicting outcome in patients with ischemic cardiomyopathy with and without defibrillators.
    Chow T, Saghir S, Bartone C, Goebel M, Schneider J, Booth T, Chan PS.
    Am J Cardiol; 2007 Aug 15; 100(4):598-604. PubMed ID: 17697813
    [Abstract] [Full Text] [Related]

  • 11. Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in chagas' heart disease.
    Martinelli M, de Siqueira SF, Sternick EB, Rassi A, Costa R, Ramires JA, Kalil Filho R.
    Am J Cardiol; 2012 Oct 01; 110(7):1040-5. PubMed ID: 22727179
    [Abstract] [Full Text] [Related]

  • 12. Impact of renal dysfunction on appropriate therapy in implantable cardioverter defibrillator patients with non-ischaemic dilated cardiomyopathy.
    Takahashi A, Shiga T, Shoda M, Manaka T, Ejima K, Hagiwara N.
    Europace; 2009 Nov 01; 11(11):1476-82. PubMed ID: 19661116
    [Abstract] [Full Text] [Related]

  • 13. Relationship between New York Heart Association class change and ventricular tachyarrhythmia occurrence in patients treated with cardiac resynchronization plus defibrillator.
    Lepillier A, Piot O, Gerritse B, Copie X, Lavergne T, Paziaud O, Lascault G, Waintraub X, Otmani A, Le Heuzey JY.
    Europace; 2009 Jan 01; 11(1):80-5. PubMed ID: 18952828
    [Abstract] [Full Text] [Related]

  • 14. [14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior].
    Vester EG, Dees H, Dobran I, Hennersdorf M, Perings C, Heydthausen M, Winter J, Strauer BE.
    Z Kardiol; 2000 Jan 01; 89 Suppl 3():194-205. PubMed ID: 10810803
    [Abstract] [Full Text] [Related]

  • 15. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
    Koller MT, Schaer B, Wolbers M, Sticherling C, Bucher HC, Osswald S.
    Circulation; 2008 Apr 15; 117(15):1918-26. PubMed ID: 18391108
    [Abstract] [Full Text] [Related]

  • 16. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study.
    Salerno-Uriarte JA, De Ferrari GM, Klersy C, Pedretti RF, Tritto M, Sallusti L, Libero L, Pettinati G, Molon G, Curnis A, Occhetta E, Morandi F, Ferrero P, Accardi F, ALPHA Study Group Investigators.
    J Am Coll Cardiol; 2007 Nov 06; 50(19):1896-904. PubMed ID: 17980258
    [Abstract] [Full Text] [Related]

  • 17. Prediction of appropriate defibrillator therapy in heart failure patients treated with cardiac resynchronization therapy.
    Soliman OI, Theuns DA, van Dalen BM, Vletter WB, Nemes A, Jordaens LJ, Balk AH, Ten Cate FJ, Geleijnse ML.
    Am J Cardiol; 2010 Jan 01; 105(1):105-11. PubMed ID: 20102900
    [Abstract] [Full Text] [Related]

  • 18. Clinical prediction model for death prior to appropriate therapy in primary prevention implantable cardioverter defibrillator patients with ischaemic heart disease: the FADES risk score.
    van Rees JB, Borleffs CJ, van Welsenes GH, van der Velde ET, Bax JJ, van Erven L, Putter H, van der Bom JG, Schalij MJ.
    Heart; 2012 Jun 01; 98(11):872-7. PubMed ID: 22581736
    [Abstract] [Full Text] [Related]

  • 19. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.
    Whang W, Mittleman MA, Rich DQ, Wang PJ, Ruskin JN, Tofler GH, Muller JE, Albert CM, TOVA Investigators.
    Circulation; 2004 Mar 23; 109(11):1386-91. PubMed ID: 14993132
    [Abstract] [Full Text] [Related]

  • 20. Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention.
    Bhonsale A, James CA, Tichnell C, Murray B, Gagarin D, Philips B, Dalal D, Tedford R, Russell SD, Abraham T, Tandri H, Judge DP, Calkins H.
    J Am Coll Cardiol; 2011 Sep 27; 58(14):1485-96. PubMed ID: 21939834
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.